nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Anaphylactic shock—Vincristine—kidney cancer	0.000896	0.000896	CcSEcCtD
Cefuroxime—Stomatitis—Capecitabine—kidney cancer	0.000892	0.000892	CcSEcCtD
Cefuroxime—Jaundice—Capecitabine—kidney cancer	0.000892	0.000892	CcSEcCtD
Cefuroxime—Urinary tract infection—Capecitabine—kidney cancer	0.00089	0.00089	CcSEcCtD
Cefuroxime—Chest pain—Gemcitabine—kidney cancer	0.000886	0.000886	CcSEcCtD
Cefuroxime—Arthralgia—Gemcitabine—kidney cancer	0.000886	0.000886	CcSEcCtD
Cefuroxime—Thrombophlebitis—Doxorubicin—kidney cancer	0.000884	0.000884	CcSEcCtD
Cefuroxime—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.00088	0.00088	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00088	0.00088	CcSEcCtD
Cefuroxime—Thrombocytopenia—Vincristine—kidney cancer	0.000877	0.000877	CcSEcCtD
Cefuroxime—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000876	0.000876	CcSEcCtD
Cefuroxime—Urticaria—Sorafenib—kidney cancer	0.000874	0.000874	CcSEcCtD
Cefuroxime—Erythema—Paclitaxel—kidney cancer	0.000872	0.000872	CcSEcCtD
Cefuroxime—Decreased appetite—Dactinomycin—kidney cancer	0.000871	0.000871	CcSEcCtD
Cefuroxime—Diarrhoea—Vinblastine—kidney cancer	0.000871	0.000871	CcSEcCtD
Cefuroxime—Abdominal pain—Sorafenib—kidney cancer	0.00087	0.00087	CcSEcCtD
Cefuroxime—Body temperature increased—Sorafenib—kidney cancer	0.00087	0.00087	CcSEcCtD
Cefuroxime—Diarrhoea—Everolimus—kidney cancer	0.000867	0.000867	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Sunitinib—kidney cancer	0.000866	0.000866	CcSEcCtD
Cefuroxime—Hyperhidrosis—Vincristine—kidney cancer	0.000866	0.000866	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Capecitabine—kidney cancer	0.000866	0.000866	CcSEcCtD
Cefuroxime—Pruritus—Erlotinib—kidney cancer	0.000865	0.000865	CcSEcCtD
Cefuroxime—Flatulence—Paclitaxel—kidney cancer	0.000859	0.000859	CcSEcCtD
Cefuroxime—Pain—Dactinomycin—kidney cancer	0.000857	0.000857	CcSEcCtD
Cefuroxime—Agranulocytosis—Capecitabine—kidney cancer	0.000854	0.000854	CcSEcCtD
Cefuroxime—Anorexia—Vincristine—kidney cancer	0.000854	0.000854	CcSEcCtD
Cefuroxime—Anaphylactic shock—Gemcitabine—kidney cancer	0.00085	0.00085	CcSEcCtD
Cefuroxime—Dizziness—Vinblastine—kidney cancer	0.000841	0.000841	CcSEcCtD
Cefuroxime—Dizziness—Everolimus—kidney cancer	0.000838	0.000838	CcSEcCtD
Cefuroxime—Muscle spasms—Paclitaxel—kidney cancer	0.000838	0.000838	CcSEcCtD
Cefuroxime—Abdominal pain—Sunitinib—kidney cancer	0.000837	0.000837	CcSEcCtD
Cefuroxime—Body temperature increased—Sunitinib—kidney cancer	0.000837	0.000837	CcSEcCtD
Cefuroxime—Diarrhoea—Erlotinib—kidney cancer	0.000837	0.000837	CcSEcCtD
Cefuroxime—Thrombocytopenia—Gemcitabine—kidney cancer	0.000832	0.000832	CcSEcCtD
Cefuroxime—Haemoglobin—Capecitabine—kidney cancer	0.000826	0.000826	CcSEcCtD
Cefuroxime—Skin disorder—Gemcitabine—kidney cancer	0.000825	0.000825	CcSEcCtD
Cefuroxime—Haemorrhage—Capecitabine—kidney cancer	0.000822	0.000822	CcSEcCtD
Cefuroxime—Hepatitis—Capecitabine—kidney cancer	0.000822	0.000822	CcSEcCtD
Cefuroxime—Hyperhidrosis—Gemcitabine—kidney cancer	0.000821	0.000821	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00082	0.00082	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000816	0.000816	CcSEcCtD
Cefuroxime—Urinary tract disorder—Capecitabine—kidney cancer	0.000811	0.000811	CcSEcCtD
Cefuroxime—Hypersensitivity—Sorafenib—kidney cancer	0.000811	0.000811	CcSEcCtD
Cefuroxime—Anorexia—Gemcitabine—kidney cancer	0.00081	0.00081	CcSEcCtD
Cefuroxime—Vomiting—Vinblastine—kidney cancer	0.000809	0.000809	CcSEcCtD
Cefuroxime—Dizziness—Erlotinib—kidney cancer	0.000809	0.000809	CcSEcCtD
Cefuroxime—Vomiting—Everolimus—kidney cancer	0.000806	0.000806	CcSEcCtD
Cefuroxime—Urethral disorder—Capecitabine—kidney cancer	0.000805	0.000805	CcSEcCtD
Cefuroxime—Renal impairment—Doxorubicin—kidney cancer	0.000804	0.000804	CcSEcCtD
Cefuroxime—Agitation—Paclitaxel—kidney cancer	0.000801	0.000801	CcSEcCtD
Cefuroxime—Rash—Everolimus—kidney cancer	0.000799	0.000799	CcSEcCtD
Cefuroxime—Dermatitis—Everolimus—kidney cancer	0.000799	0.000799	CcSEcCtD
Cefuroxime—Headache—Vinblastine—kidney cancer	0.000797	0.000797	CcSEcCtD
Cefuroxime—Angioedema—Paclitaxel—kidney cancer	0.000796	0.000796	CcSEcCtD
Cefuroxime—Headache—Everolimus—kidney cancer	0.000794	0.000794	CcSEcCtD
Cefuroxime—Abdominal pain—Dactinomycin—kidney cancer	0.000792	0.000792	CcSEcCtD
Cefuroxime—Body temperature increased—Dactinomycin—kidney cancer	0.000792	0.000792	CcSEcCtD
Cefuroxime—Leukopenia—Paclitaxel—kidney cancer	0.00078	0.00078	CcSEcCtD
Cefuroxime—Hypersensitivity—Sunitinib—kidney cancer	0.00078	0.00078	CcSEcCtD
Cefuroxime—Decreased appetite—Vincristine—kidney cancer	0.000779	0.000779	CcSEcCtD
Cefuroxime—Pruritus—Sorafenib—kidney cancer	0.000778	0.000778	CcSEcCtD
Cefuroxime—Vomiting—Erlotinib—kidney cancer	0.000778	0.000778	CcSEcCtD
Cefuroxime—Erythema multiforme—Capecitabine—kidney cancer	0.000777	0.000777	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000774	0.000774	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Vincristine—kidney cancer	0.000773	0.000773	CcSEcCtD
Cefuroxime—Rash—Erlotinib—kidney cancer	0.000771	0.000771	CcSEcCtD
Cefuroxime—Dermatitis—Erlotinib—kidney cancer	0.00077	0.00077	CcSEcCtD
Cefuroxime—Palpitations—Paclitaxel—kidney cancer	0.00077	0.00077	CcSEcCtD
Cefuroxime—Headache—Erlotinib—kidney cancer	0.000766	0.000766	CcSEcCtD
Cefuroxime—Pain—Vincristine—kidney cancer	0.000766	0.000766	CcSEcCtD
Cefuroxime—Cough—Paclitaxel—kidney cancer	0.000761	0.000761	CcSEcCtD
Cefuroxime—Dyspnoea—Gemcitabine—kidney cancer	0.000757	0.000757	CcSEcCtD
Cefuroxime—Nausea—Vinblastine—kidney cancer	0.000756	0.000756	CcSEcCtD
Cefuroxime—Somnolence—Gemcitabine—kidney cancer	0.000755	0.000755	CcSEcCtD
Cefuroxime—Convulsion—Paclitaxel—kidney cancer	0.000755	0.000755	CcSEcCtD
Cefuroxime—Nausea—Everolimus—kidney cancer	0.000753	0.000753	CcSEcCtD
Cefuroxime—Diarrhoea—Sorafenib—kidney cancer	0.000753	0.000753	CcSEcCtD
Cefuroxime—Pruritus—Sunitinib—kidney cancer	0.000749	0.000749	CcSEcCtD
Cefuroxime—Angiopathy—Capecitabine—kidney cancer	0.000745	0.000745	CcSEcCtD
Cefuroxime—Immune system disorder—Capecitabine—kidney cancer	0.000742	0.000742	CcSEcCtD
Cefuroxime—Arthralgia—Paclitaxel—kidney cancer	0.000742	0.000742	CcSEcCtD
Cefuroxime—Chest pain—Paclitaxel—kidney cancer	0.000742	0.000742	CcSEcCtD
Cefuroxime—Decreased appetite—Gemcitabine—kidney cancer	0.000739	0.000739	CcSEcCtD
Cefuroxime—Hypersensitivity—Dactinomycin—kidney cancer	0.000738	0.000738	CcSEcCtD
Cefuroxime—Chills—Capecitabine—kidney cancer	0.000737	0.000737	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000737	0.000737	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000733	0.000733	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Vincristine—kidney cancer	0.000732	0.000732	CcSEcCtD
Cefuroxime—Dizziness—Sorafenib—kidney cancer	0.000728	0.000728	CcSEcCtD
Cefuroxime—Pain—Gemcitabine—kidney cancer	0.000727	0.000727	CcSEcCtD
Cefuroxime—Nausea—Erlotinib—kidney cancer	0.000727	0.000727	CcSEcCtD
Cefuroxime—Diarrhoea—Sunitinib—kidney cancer	0.000724	0.000724	CcSEcCtD
Cefuroxime—Blood creatinine increased—Doxorubicin—kidney cancer	0.000717	0.000717	CcSEcCtD
Cefuroxime—Erythema—Capecitabine—kidney cancer	0.000715	0.000715	CcSEcCtD
Cefuroxime—Anaphylactic shock—Paclitaxel—kidney cancer	0.000711	0.000711	CcSEcCtD
Cefuroxime—Abdominal pain—Vincristine—kidney cancer	0.000708	0.000708	CcSEcCtD
Cefuroxime—Body temperature increased—Vincristine—kidney cancer	0.000708	0.000708	CcSEcCtD
Cefuroxime—Flatulence—Capecitabine—kidney cancer	0.000705	0.000705	CcSEcCtD
Cefuroxime—Dizziness—Sunitinib—kidney cancer	0.0007	0.0007	CcSEcCtD
Cefuroxime—Vomiting—Sorafenib—kidney cancer	0.0007	0.0007	CcSEcCtD
Cefuroxime—Thrombocytopenia—Paclitaxel—kidney cancer	0.000696	0.000696	CcSEcCtD
Cefuroxime—Tachycardia—Paclitaxel—kidney cancer	0.000694	0.000694	CcSEcCtD
Cefuroxime—Rash—Sorafenib—kidney cancer	0.000694	0.000694	CcSEcCtD
Cefuroxime—Dermatitis—Sorafenib—kidney cancer	0.000693	0.000693	CcSEcCtD
Cefuroxime—Skin disorder—Paclitaxel—kidney cancer	0.000691	0.000691	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000689	0.000689	CcSEcCtD
Cefuroxime—Headache—Sorafenib—kidney cancer	0.000689	0.000689	CcSEcCtD
Cefuroxime—Muscle spasms—Capecitabine—kidney cancer	0.000688	0.000688	CcSEcCtD
Cefuroxime—Hyperhidrosis—Paclitaxel—kidney cancer	0.000688	0.000688	CcSEcCtD
Cefuroxime—Diarrhoea—Dactinomycin—kidney cancer	0.000686	0.000686	CcSEcCtD
Cefuroxime—Anorexia—Paclitaxel—kidney cancer	0.000678	0.000678	CcSEcCtD
Cefuroxime—Vomiting—Sunitinib—kidney cancer	0.000673	0.000673	CcSEcCtD
Cefuroxime—Body temperature increased—Gemcitabine—kidney cancer	0.000672	0.000672	CcSEcCtD
Cefuroxime—Rash—Sunitinib—kidney cancer	0.000668	0.000668	CcSEcCtD
Cefuroxime—Dermatitis—Sunitinib—kidney cancer	0.000667	0.000667	CcSEcCtD
Cefuroxime—Headache—Sunitinib—kidney cancer	0.000663	0.000663	CcSEcCtD
Cefuroxime—Hypersensitivity—Vincristine—kidney cancer	0.00066	0.00066	CcSEcCtD
Cefuroxime—Eosinophilia—Doxorubicin—kidney cancer	0.000655	0.000655	CcSEcCtD
Cefuroxime—Nausea—Sorafenib—kidney cancer	0.000654	0.000654	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000648	0.000648	CcSEcCtD
Cefuroxime—Leukopenia—Capecitabine—kidney cancer	0.00064	0.00064	CcSEcCtD
Cefuroxime—Vomiting—Dactinomycin—kidney cancer	0.000637	0.000637	CcSEcCtD
Cefuroxime—Bronchitis—Doxorubicin—kidney cancer	0.000636	0.000636	CcSEcCtD
Cefuroxime—Dyspnoea—Paclitaxel—kidney cancer	0.000634	0.000634	CcSEcCtD
Cefuroxime—Somnolence—Paclitaxel—kidney cancer	0.000632	0.000632	CcSEcCtD
Cefuroxime—Palpitations—Capecitabine—kidney cancer	0.000632	0.000632	CcSEcCtD
Cefuroxime—Rash—Dactinomycin—kidney cancer	0.000632	0.000632	CcSEcCtD
Cefuroxime—Nausea—Sunitinib—kidney cancer	0.000629	0.000629	CcSEcCtD
Cefuroxime—Pancytopenia—Doxorubicin—kidney cancer	0.000628	0.000628	CcSEcCtD
Cefuroxime—Dyspepsia—Paclitaxel—kidney cancer	0.000626	0.000626	CcSEcCtD
Cefuroxime—Cough—Capecitabine—kidney cancer	0.000624	0.000624	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—kidney cancer	0.000619	0.000619	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—kidney cancer	0.000619	0.000619	CcSEcCtD
Cefuroxime—Decreased appetite—Paclitaxel—kidney cancer	0.000618	0.000618	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000615	0.000615	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000614	0.000614	CcSEcCtD
Cefuroxime—Diarrhoea—Vincristine—kidney cancer	0.000613	0.000613	CcSEcCtD
Cefuroxime—Chest pain—Capecitabine—kidney cancer	0.000609	0.000609	CcSEcCtD
Cefuroxime—Arthralgia—Capecitabine—kidney cancer	0.000609	0.000609	CcSEcCtD
Cefuroxime—Pain—Paclitaxel—kidney cancer	0.000608	0.000608	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000605	0.000605	CcSEcCtD
Cefuroxime—Pruritus—Gemcitabine—kidney cancer	0.000601	0.000601	CcSEcCtD
Cefuroxime—Nausea—Dactinomycin—kidney cancer	0.000595	0.000595	CcSEcCtD
Cefuroxime—Dizziness—Vincristine—kidney cancer	0.000592	0.000592	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—kidney cancer	0.00059	0.00059	CcSEcCtD
Cefuroxime—Infestation NOS—Doxorubicin—kidney cancer	0.00059	0.00059	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—kidney cancer	0.00059	0.00059	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000585	0.000585	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000582	0.000582	CcSEcCtD
Cefuroxime—Diarrhoea—Gemcitabine—kidney cancer	0.000581	0.000581	CcSEcCtD
Cefuroxime—Renal failure—Doxorubicin—kidney cancer	0.00058	0.00058	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—kidney cancer	0.000575	0.000575	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—kidney cancer	0.000575	0.000575	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—kidney cancer	0.000573	0.000573	CcSEcCtD
Cefuroxime—Thrombocytopenia—Capecitabine—kidney cancer	0.000572	0.000572	CcSEcCtD
Cefuroxime—Tachycardia—Capecitabine—kidney cancer	0.00057	0.00057	CcSEcCtD
Cefuroxime—Vomiting—Vincristine—kidney cancer	0.000569	0.000569	CcSEcCtD
Cefuroxime—Skin disorder—Capecitabine—kidney cancer	0.000567	0.000567	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—kidney cancer	0.000566	0.000566	CcSEcCtD
Cefuroxime—Urticaria—Paclitaxel—kidney cancer	0.000565	0.000565	CcSEcCtD
Cefuroxime—Rash—Vincristine—kidney cancer	0.000565	0.000565	CcSEcCtD
Cefuroxime—Hyperhidrosis—Capecitabine—kidney cancer	0.000564	0.000564	CcSEcCtD
Cefuroxime—Dermatitis—Vincristine—kidney cancer	0.000564	0.000564	CcSEcCtD
Cefuroxime—Body temperature increased—Paclitaxel—kidney cancer	0.000562	0.000562	CcSEcCtD
Cefuroxime—Abdominal pain—Paclitaxel—kidney cancer	0.000562	0.000562	CcSEcCtD
Cefuroxime—Headache—Vincristine—kidney cancer	0.000561	0.000561	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000558	0.000558	CcSEcCtD
Cefuroxime—Anorexia—Capecitabine—kidney cancer	0.000556	0.000556	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—kidney cancer	0.000553	0.000553	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—kidney cancer	0.000551	0.000551	CcSEcCtD
Cefuroxime—Vomiting—Gemcitabine—kidney cancer	0.00054	0.00054	CcSEcCtD
Cefuroxime—Rash—Gemcitabine—kidney cancer	0.000536	0.000536	CcSEcCtD
Cefuroxime—Dermatitis—Gemcitabine—kidney cancer	0.000535	0.000535	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—kidney cancer	0.000532	0.000532	CcSEcCtD
Cefuroxime—Headache—Gemcitabine—kidney cancer	0.000532	0.000532	CcSEcCtD
Cefuroxime—Nausea—Vincristine—kidney cancer	0.000532	0.000532	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000532	0.000532	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—kidney cancer	0.00053	0.00053	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—kidney cancer	0.00053	0.00053	CcSEcCtD
Cefuroxime—Hypersensitivity—Paclitaxel—kidney cancer	0.000524	0.000524	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—kidney cancer	0.000523	0.000523	CcSEcCtD
Cefuroxime—Dyspnoea—Capecitabine—kidney cancer	0.00052	0.00052	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—kidney cancer	0.000519	0.000519	CcSEcCtD
Cefuroxime—Dyspepsia—Capecitabine—kidney cancer	0.000514	0.000514	CcSEcCtD
Cefuroxime—Decreased appetite—Capecitabine—kidney cancer	0.000507	0.000507	CcSEcCtD
Cefuroxime—Nausea—Gemcitabine—kidney cancer	0.000505	0.000505	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000504	0.000504	CcSEcCtD
Cefuroxime—Pruritus—Paclitaxel—kidney cancer	0.000503	0.000503	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—kidney cancer	0.000501	0.000501	CcSEcCtD
Cefuroxime—Pain—Capecitabine—kidney cancer	0.000499	0.000499	CcSEcCtD
Cefuroxime—Diarrhoea—Paclitaxel—kidney cancer	0.000487	0.000487	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—kidney cancer	0.000481	0.000481	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—kidney cancer	0.000478	0.000478	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Capecitabine—kidney cancer	0.000477	0.000477	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—kidney cancer	0.000475	0.000475	CcSEcCtD
Cefuroxime—Dizziness—Paclitaxel—kidney cancer	0.00047	0.00047	CcSEcCtD
Cefuroxime—Urticaria—Capecitabine—kidney cancer	0.000464	0.000464	CcSEcCtD
Cefuroxime—Abdominal pain—Capecitabine—kidney cancer	0.000461	0.000461	CcSEcCtD
Cefuroxime—Body temperature increased—Capecitabine—kidney cancer	0.000461	0.000461	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—kidney cancer	0.000461	0.000461	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—kidney cancer	0.000454	0.000454	CcSEcCtD
Cefuroxime—Vomiting—Paclitaxel—kidney cancer	0.000452	0.000452	CcSEcCtD
Cefuroxime—Rash—Paclitaxel—kidney cancer	0.000448	0.000448	CcSEcCtD
Cefuroxime—Dermatitis—Paclitaxel—kidney cancer	0.000448	0.000448	CcSEcCtD
Cefuroxime—Headache—Paclitaxel—kidney cancer	0.000446	0.000446	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—kidney cancer	0.000443	0.000443	CcSEcCtD
Cefuroxime—Hypersensitivity—Capecitabine—kidney cancer	0.00043	0.00043	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—kidney cancer	0.000424	0.000424	CcSEcCtD
Cefuroxime—Nausea—Paclitaxel—kidney cancer	0.000423	0.000423	CcSEcCtD
Cefuroxime—Pruritus—Capecitabine—kidney cancer	0.000413	0.000413	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—kidney cancer	0.000413	0.000413	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—kidney cancer	0.000407	0.000407	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—kidney cancer	0.000402	0.000402	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—kidney cancer	0.000399	0.000399	CcSEcCtD
Cefuroxime—Diarrhoea—Capecitabine—kidney cancer	0.000399	0.000399	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—kidney cancer	0.000393	0.000393	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—kidney cancer	0.000393	0.000393	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.00039	0.00039	CcSEcCtD
Cefuroxime—Dizziness—Capecitabine—kidney cancer	0.000386	0.000386	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—kidney cancer	0.000376	0.000376	CcSEcCtD
Cefuroxime—Vomiting—Capecitabine—kidney cancer	0.000371	0.000371	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—kidney cancer	0.000368	0.000368	CcSEcCtD
Cefuroxime—Rash—Capecitabine—kidney cancer	0.000368	0.000368	CcSEcCtD
Cefuroxime—Dermatitis—Capecitabine—kidney cancer	0.000368	0.000368	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—kidney cancer	0.000367	0.000367	CcSEcCtD
Cefuroxime—Headache—Capecitabine—kidney cancer	0.000366	0.000366	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—kidney cancer	0.000365	0.000365	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—kidney cancer	0.000364	0.000364	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—kidney cancer	0.000359	0.000359	CcSEcCtD
Cefuroxime—Nausea—Capecitabine—kidney cancer	0.000347	0.000347	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000343	0.000343	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—kidney cancer	0.000335	0.000335	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—kidney cancer	0.000335	0.000335	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—kidney cancer	0.000331	0.000331	CcSEcCtD
Cefuroxime—Decreased appetite—Doxorubicin—kidney cancer	0.000327	0.000327	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000325	0.000325	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—kidney cancer	0.000322	0.000322	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000308	0.000308	CcSEcCtD
Cefuroxime—Urticaria—Doxorubicin—kidney cancer	0.000299	0.000299	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—kidney cancer	0.000297	0.000297	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—kidney cancer	0.000297	0.000297	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—kidney cancer	0.000277	0.000277	CcSEcCtD
Cefuroxime—Pruritus—Doxorubicin—kidney cancer	0.000266	0.000266	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—kidney cancer	0.000257	0.000257	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—kidney cancer	0.000249	0.000249	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—kidney cancer	0.000239	0.000239	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—kidney cancer	0.000237	0.000237	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—kidney cancer	0.000237	0.000237	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—kidney cancer	0.000236	0.000236	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—kidney cancer	0.000223	0.000223	CcSEcCtD
